Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Delfín, Dawn A ^a   Xu, Ying ^a   Peterson, Jennifer M ^b   Guttridge, Denis C ^b   Rafael Fortney, Jill A ^a   Janssen, Paul M L ^a  

^a Department of Molecular and Cellular Biochemistry ^*  (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR; BIOLOGICAL MARKER; COLLAGEN; DYSTROPHIN; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UTROPHIN; PEPTIDE;

ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CELL DEGENERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DYSTROPHIN GENE; FEMALE; GENE; HEART FAILURE; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HISTOPATHOLOGY; IN VITRO STUDY; MALE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; OUTCOME ASSESSMENT; PROTEIN DOMAIN; SIGNAL TRANSDUCTION; TRANSCRIPTION TERMINATION; UTROPHIN GENE; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; DISEASE MODEL; DRUG ANTAGONISM; HEART CONTRACTION; HEART MUSCLE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; DYSTROPHIN; MICE; MICE, KNOCKOUT; MUSCULAR DYSTROPHY, ANIMAL; MYOCARDIAL CONTRACTION; MYOCARDIUM; NF-KAPPA B; PEPTIDES; RECEPTORS, ADRENERGIC, BETA; UTROPHIN;

EID: 79955975411     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-68     Document Type: Article

References (34)

1. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
2. McNally EM. New approaches in the therapy of cardiomyopathy in muscular dystrophy. Annual Review of Medicine 2007, 58:75-88. 10.1146/annurev.med.58.011706.144703, 17217326.
3. Duan D. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum
4. Townsend D, Yasuda S, Li S, Chamberlain JS, Metzger JM. Emergent dilated cardiomyopathy caused by targeted repair of dystrophic skeletal muscle. Mol Ther 2008, 16:832-835. 10.1038/mt.2008.52, 2592846, 18414480.
5. Acharyya S, Villalta SA, Bakkar N, Bupha-Intr T, Janssen PML, Carathers M, Li ZW, Beg AA, Ghosh S, Sahenk Z, Weinstein M, Gardner KL, Rafael-Fortney JA, Karin M, Tidball JG, Baldwin AS, Guttridge DC. Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 2007, 117:889-901. 10.1172/JCI30556, 1821069, 17380205.
6. Peterson JM, Kline W, Canan BD, Ricca DJ, Kaspar BK, Delfín DA, DiRienzo K, Clemens PR, Robbins PD, Baldwin AS, Flood P, Kaumaya P, Freitas M, Kornegay JN, Mendell JR, Rafael-Fortney JA, Guttridge DC, Janssen PML. Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Molecular Medicine 2011,
7. Guerron AD, Rawat R, Sali A, Spurney CF, Pistilli E, Cha HJ, Pandey GS, Gernapudi R, Francia D, Farajian V, Escolar DM, Bossi L, Becker M, Zerr P, de la Porte S, Gordish-Dressman H, Partridge T, Hoffman EP, Nagaraju K. Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy. PLoS One 2010, 5:e11220. 10.1371/journal.pone.0011220, 2888587, 20574530.
8. Bushby K, Lochmuller H, Lynn S, Straub V. Interventions for muscular dystrophy: molecular medicines entering the clinic. Lancet 2009, 374:1849-1856. 10.1016/S0140-6736(09)61834-1, 19944865.
9. Deconinck AE, Rafael JA, Skinner JA, Brown SC, Potter AC, Metzinger L, Watt DJ, Dickson JG, Tinsley JM, Davies KE. Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 1997, 90:717-727. 10.1016/S0092-8674(00)80532-2, 9288751.
10. Janssen PML, Hiranandani N, Mays TA, Rafael-Fortney JA. Utrophin deficiency worsens cardiac contractile dysfunction present in dystrophin-deficient mdx mice. Am J Physiol Heart Circ Physiol 2005, 289:H2373-2378. 10.1152/ajpheart.00448.2005, 16024571.
11. Mulieri LA, Hasenfuss G, Leavitt B, Allen PD, Alpert NR. Altered myocardial force-frequency relation in human heart failure. Circulation 1992, 85:1743-1750.
12. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 1982, 307:205-211. 10.1056/NEJM198207223070401, 6283349.
13. Hainsey TA, Senapati S, Kuhn DE, Rafael JA. Cardiomyopathic features associated with muscular dystrophy are independent of dystrophin absence in cardiovasculature. Neuromuscul Disord 2003, 13:294-302. 10.1016/S0960-8966(02)00286-9, 12868498.
14. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003, 99:1-19. 10.1159/000068446, 14685699.
15. Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacology and Therapeutics 2009, 123:255-278. 10.1016/j.pharmthera.2009.05.002, 19460403.
16. Fedak PW, Verma S, Weisel RD, Li RK. Cardiac remodeling and failure From molecules to man (Part II). Cardiovasc Pathol 2005, 14:49-60. 10.1016/j.carpath.2005.01.005, 15780796.
17. May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science 2000, 289:1550-1554. 10.1126/science.289.5484.1550, 10968790.
18. Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1. Mol Cell Biol 1999, 19:5785-5799. 84428, 10409765.
19. Stull LB, Leppo M, Marban E, Janssen PML. Physiological determinants of contractile force generation and calcium handling in mouse myocardium. J Mol Cell Cardiol 2002, 34:1367-1376. 10.1006/jmcc.2002.2065, 12392997.
20. Janssen PML. Kinetics of Cardiac Muscle Contraction and Relaxation are Linked and Determined by Properties of the Cardiac Sarcomere. Am J Physiol Heart Circ Physiol 2010, 299(4):H1092-9. 10.1152/ajpheart.00417.2010, 20656885.
21. ter Keurs HE, Rijnsburger WH, van Heuningen R, Nagelsmit MJ. Tension development and sarcomere length in rat cardiac trabeculae. Evidence of length-dependent activation. Circ Res 1980, 46:703-714.
22. Janssen PML. 54th Bowditch Lecture: Myocardial Contraction-Relaxation Coupling. Am J Physiol Heart Circ Physiol 2010, 299(6):H1741-9. 10.1152/ajpheart.00759.2010, 20852049.
23. Janssen PML, Hunter WC. Force, not sarcomere length, correlates with prolongation of isosarcometric contraction. Am J Physiol Heart Circ Physiol 1995, 269:H676-685.
24. Janssen PML, Periasamy M. Determinants of frequency-dependent contraction and relaxation of mammalian myocardium. J Mol Cell Cardiol 2007, 43:523-531. 10.1016/j.yjmcc.2007.08.012, 2093987, 17919652.
25. Rossman EI, Petre RE, Chaudhary KW, Piacentino V, Janssen PML, Gaughan JP, Houser SR, Margulies KB. Abnormal frequency-dependent responses represent the pathophysiologic signature of contractile failure in human myocardium. J Mol Cell Cardiol 2004, 36:33-42. 10.1016/j.yjmcc.2003.09.001, 14734045.
26. de Tombe PP, Wannenburg T, Fan D, Little WC. Right ventricular contractile protein function in rats with left ventricular myocardial infarction. Am J Physiol Heart Circ Physiol 1996, 271:H73-79.
27. Georgakopoulos D, Kass D. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart. J Physiol 2001, 534:535-545. 10.1111/j.1469-7793.2001.00535.x, 2278704, 11454970.
28. Shi XZ, Pazdrak K, Saada N, Dai B, Palade P, Sarna SK. Negative transcriptional regulation of human colonic smooth muscle Cav1.2 channels by p50 and p65 subunits of nuclear factor-kappaB. Gastroenterology 2005, 129:1518-1532. 10.1053/j.gastro.2005.07.058, 16285952.
29. Tonnesen MF, Grunnet LG, Friberg J, Cardozo AK, Billestrup N, Eizirik DL, Storling J, Mandrup-Poulsen T. Inhibition of nuclear factor-kappaB or Bax prevents endoplasmic reticulum stress- but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 2009, 150:4094-4103. 10.1210/en.2009-0029, 19556421.
30. Lima-Cabello E, Cuevas MJ, Garatachea N, Baldini M, Almar M, Gonzalez-Gallego J. Eccentric exercise induces nitric oxide synthase expression through nuclear factor-kappaB modulation in rat skeletal muscle. J Appl Physiol 2010, 108:575-583. 10.1152/japplphysiol.00816.2009, 20044475.
31. Panama BK, Latour-Villamil D, Farman GP, Zhao D, Bolz SS, Kirshenbaum LA, Backx PH. Nuclear Factor kappaB Downregulates the Transient Outward Potassium Current I(to,f) Through Control of KChIP2 Expression. Circ Res 2011, 108:537-543. 10.1161/CIRCRESAHA.110.229112, 21252158.
32. Li D, Yue Y, Duan D. Preservation of muscle force in Mdx3cv mice correlates with low-level expression of a near full-length dystrophin protein. Am J Pathol 2008, 172:1332-1341. 10.2353/ajpath.2008.071042, 2329842, 18385524.
33. Bostick B, Yue Y, Lai Y, Long C, Li D, Duan D. Adeno-associated virus serotype-9 microdystrophin gene therapy ameliorates electrocardiographic abnormalities in mdx mice. Hum Gene Ther 2008, 19:851-856. 10.1089/hum.2008.058, 2888653,2888653, 18666839.
34. Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D. Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Ther 2009, 17:253-261. 10.1038/mt.2008.264, 2714701,2714701, 19066599.